1Cell.Ai

Mumbai, India Founded: 2021 • Age: 5 yrs
AI-powered single-cell multi-omic analysis tools for precision oncology are developed.

About 1Cell.Ai

1Cell.Ai is a company based in Mumbai (India) founded in 2021 by Mohan Uttarwar. It operates as a AI-as-a-Service, and HealthTech. 1Cell.Ai has raised $16 million across 1 funding round from investors including Cedars Sinai, Tenacity Ventures and Celesta. 1Cell.Ai offers products and services including OncoIncytes®, 1Cell SOLO®, and 1Cell iCore™.

  • Headquarter Mumbai, India
  • Founders Mohan Uttarwar
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Health Technology & Digital Health
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $16 M (USD)

    in 1 rounds

  • Latest Funding Round
    $16 M (USD), Series A

    Nov 22, 2024

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of 1Cell.Ai

1Cell.Ai offers a comprehensive portfolio of products and services, including OncoIncytes®, 1Cell SOLO®, and 1Cell iCore™. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Advanced platform for cancer profiling and insights delivery.

AI-driven system for precise tumor cell analysis.

Integrated AI ecosystem for oncology data management.

People of 1Cell.Ai
Headcount 50-200
Employee Profiles 5
Employee Profiles
People
Sarita Lawrence
General Manager Marketing
People
Sankar Mohan
Senior Director Of Scientific Operations
People
Jayant Khandare
Chief Scientific Officer
People
Bhagwat Jadhav
Research Scientist

Unlock access to complete

Funding Insights of 1Cell.Ai

1Cell.Ai has successfully raised a total of $16M through 1 strategic funding round. The most recent funding activity was a Series A round of $16 million completed in November 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 1
  • Last Round Series A — $16.0M
  • First Round

    (22 Nov 2024)

  • Investors Count 5
Date Amount Transaction Name Valuation Lead Investors Investors
Nov, 2024 Amount Series A - 1Cell.Ai Valuation Celesta Capital
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in 1Cell.Ai

1Cell.Ai has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Cedars Sinai, Tenacity Ventures and Celesta. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Venture capital firm focused on multiple sectors
Founded Year Domain Location
Technology investment firm focusing on early-growth stages and software businesses in India.
Founded Year Domain Location
-
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by 1Cell.Ai

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - 1Cell.Ai

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

1Cell.Ai Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of 1Cell.Ai

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on 1Cell.Ai

Frequently Asked Questions about 1Cell.Ai

When was 1Cell.Ai founded?

1Cell.Ai was founded in 2021 and raised its 1st funding round 3 years after it was founded.

Where is 1Cell.Ai located?

1Cell.Ai is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

Who is the current CEO of 1Cell.Ai?

Mohan Uttarwar is the current CEO of 1Cell.Ai. They have also founded this company.

Is 1Cell.Ai a funded company?

1Cell.Ai is a funded company, having raised a total of $16M across 1 funding round to date. The company's 1st funding round was a Series A of $16M, raised on Nov 22, 2024.

What does 1Cell.Ai do?

Advanced AI technology and single-cell multi-omics are combined by 1Cell.Ai to transform cancer diagnostics and care. Precision insights for clinicians, researchers, and biopharma partners are delivered through a next-generation platform. Solutions for earlier detection, personalized treatment, and continuous monitoring in oncology are offered. The focus is placed on integrating molecular science with machine learning to address tumor heterogeneity and disease evolution. Real-time data analytics and tailored treatment strategies are supported across clinical trials and research studies.

What products or services does 1Cell.Ai offer?

1Cell.Ai offers OncoIncytes®, 1Cell SOLO®, and 1Cell iCore™.

Who are 1Cell.Ai's investors?

1Cell.Ai has 5 investors. Key investors include Cedars Sinai, Tenacity Ventures, Celesta, Eragon, and Singularity Venture Partners.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available